Showing results 9 to 12 of 12
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitors Journal:Current Medical Research and Opinion | 2020 | 25 | ||
2017 | ||||
2020 | ||||
Upregulation of Immune Response Biomarkers by Ribociclib Plus Endocrine Therapy in Paired Tumor Samples From Phase I Studies Proceeding/Conference:San Antonio Breast Cancer Symposium 2021 | 2021 | 8 |